Please Wait
Applying Filters...
menu
    • menu
    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    An Enquiry

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    RX-5902

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    2D Structure
    Also known as: 888478-45-3, Rx-5902, P-p68 inhibitor rx-5902, Zu8om8v5wf, 4-(3,5-dimethoxyphenyl)-n-(7-fluoro-3-methoxy-quinoxalin-2-yl)piperazine-1-carboxamide, 4-(3,5-dimethoxyphenyl)-n-(7-fluoro-3-methoxyquinoxalin-2-yl)piperazine-1-carboxamide
    Molecular Formula
    C22H24FN5O4
    Molecular Weight
    441.5  g/mol
    InChI Key
    KAKPGJJRYRYSTP-UHFFFAOYSA-N
    FDA UNII
    ZU8OM8V5WF
    P-p68 Inhibitor RX-5902 is an orally bioavailable small molecule inhibitor of phosphorylated-p68 RNA helicase (P-p68), with potential anti-proliferative and antineoplastic activity. Upon oral administration, P-p68 inhibitor RX-5902 may both inhibit the activity of the anti-apoptotic B-cell lymphoma 2 (Bcl-2) protein and facilitate the induction of cyclin-dependent kinase inhibitor 1 (p21). This may prevent G2/M cell cycle progression and lead to growth inhibition in tumor cells. P-p68 is overexpressed in various types of solid tumors but absent in normal tissues, and plays a role in tumor progression and metastasis. p21 is a potent cyclin-dependent kinase inhibitor which regulates cell cycle progression and mediates both growth arrest and cellular senescence.
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    4-(3,5-dimethoxyphenyl)-N-(7-fluoro-3-methoxyquinoxalin-2-yl)piperazine-1-carboxamide
    2.1.2 InChI
    InChI=1S/C22H24FN5O4/c1-30-16-11-15(12-17(13-16)31-2)27-6-8-28(9-7-27)22(29)26-20-21(32-3)25-18-5-4-14(23)10-19(18)24-20/h4-5,10-13H,6-9H2,1-3H3,(H,24,26,29)
    2.1.3 InChI Key
    KAKPGJJRYRYSTP-UHFFFAOYSA-N
    2.1.4 Canonical SMILES
    COC1=CC(=CC(=C1)N2CCN(CC2)C(=O)NC3=NC4=C(C=CC(=C4)F)N=C3OC)OC
    2.2 Other Identifiers
    2.2.1 UNII
    ZU8OM8V5WF
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. 1-(3,5-dimethoxyphenyl)-4-((6-fluoro-2-methoxyquinoxalin-3-yl)aminocarbonyl)piperazine

    2. Rx-5902

    2.3.2 Depositor-Supplied Synonyms

    1. 888478-45-3

    2. Rx-5902

    3. P-p68 Inhibitor Rx-5902

    4. Zu8om8v5wf

    5. 4-(3,5-dimethoxyphenyl)-n-(7-fluoro-3-methoxy-quinoxalin-2-yl)piperazine-1-carboxamide

    6. 4-(3,5-dimethoxyphenyl)-n-(7-fluoro-3-methoxyquinoxalin-2-yl)piperazine-1-carboxamide

    7. 1-(3,5-dimethoxyphenyl)-4-((6-fluoro-2-methoxyquinoxalin-3-yl)aminocarbonyl) Piperazine

    8. 1-piperazinecarboxamide, 4-(3,5-dimethoxyphenyl)-n-(7-fluoro-3-methoxy-2-quinoxalinyl)-

    9. Unii-zu8om8v5wf

    10. Schembl1137972

    11. Chembl1278118

    12. Rx-5902 (supinoxin)

    13. Ex-a4696

    14. Nsc779374

    15. Nsc793148

    16. Nsc-779374

    17. Nsc-793148

    18. Sb19791

    19. Hy-123611

    20. Cs-0083830

    21. 1-[(6-fluoro-2-methoxyquinoxalin-3-yl)aminocarbonyl]-4-(3,5-dimethoxyphenyl)piperazine

    2.4 Create Date
    2006-10-26
    3 Chemical and Physical Properties
    Molecular Weight 441.5 g/mol
    Molecular Formula C22H24FN5O4
    XLogP32.7
    Hydrogen Bond Donor Count1
    Hydrogen Bond Acceptor Count8
    Rotatable Bond Count5
    Exact Mass441.18123243 g/mol
    Monoisotopic Mass441.18123243 g/mol
    Topological Polar Surface Area89 Ų
    Heavy Atom Count32
    Formal Charge0
    Complexity611
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.